Order Article Reprints

Facchini G, D’Arienzo A, Nicastro A, Flauto F, Izzo M, Montella L, Riccardo F, Fusco GM, Trama F, Lauro GD, et al. Apalutamide Monotherapy in Metastatic Hormone-Sensitive Prostate Cancer: A Viable Alternative to First-Generation Anti-Androgen Agents to Avoid the Flare Phenomenon and an Effective Treatment for Achieving Early PSA Response. Cancers. 2025; 17(15):2573. https://doi.org/10.3390/cancers17152573

Facchini, Gaetano, Andrea D’Arienzo, Antonella Nicastro, Fabiano Flauto, Michela Izzo, Liliana Montella, Filippo Riccardo, Giovanni Maria Fusco, Francesco Trama, Giovanni Di Lauro, and et al. 2025. "Apalutamide Monotherapy in Metastatic Hormone-Sensitive Prostate Cancer: A Viable Alternative to First-Generation Anti-Androgen Agents to Avoid the Flare Phenomenon and an Effective Treatment for Achieving Early PSA Response" Cancers 17, no. 15: 2573. https://doi.org/10.3390/cancers17152573

Facchini, G., D’Arienzo, A., Nicastro, A., Flauto, F., Izzo, M., Montella, L., Riccardo, F., Fusco, G. M., Trama, F., Lauro, G. D., Costanzo, G. D., Tucci, A. G., Iasiello, F., Di Lorenzo, L., Maddaluno, S., Liguori, C., Cupillo, R. A. d., Coppola, P., Minissale, A., ... Barraco, C. (2025). Apalutamide Monotherapy in Metastatic Hormone-Sensitive Prostate Cancer: A Viable Alternative to First-Generation Anti-Androgen Agents to Avoid the Flare Phenomenon and an Effective Treatment for Achieving Early PSA Response. Cancers, 17(15), 2573. https://doi.org/10.3390/cancers17152573